” Whilst the Ricaurte Tale was unfolding, MAPS at last received FDA signal-off over a protocol for human trials of MDMA like a therapy for PTSD, but only just after it acquired a $1 million insurance plan plan to indemnify the assessment board.While in the nineteen nineties, the FDA approved the initial human trial examining utilization of MDMA T